1. Assessing the Risk for Gout With SGLT2 Inhibitors in Patients With Diabetes  Annals of Internal Medicine
  2. Diabetes Drug Class May Hold Promise for Gout Prevention  Medscape
  3. Certain Diabetes Meds May Lower Gout Risk, Too  U.S. News & World Report
  4. View full coverage on Google News

Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.

Diabetes Drug Class May Hold Promise for Gout Prevention

Access Denied